Tech Company Financing Transactions
Edimer Pharmaceuticals Funding Round
Edimer Pharmaceuticals, based in Cambridge, secured $18 million in investment from New Enterprise Associates, Sanofi-Genzyme BioVentures and Third Rock Ventures.
Transaction Overview
New Enterprise Associates (Lead Investor) (David Mott)
Sanofi-Genzyme BioVentures (Bernard Davitian)
Third Rock Ventures (Cary Pfeffer)
Company Information
Cambridge, MA 02142
USA
Management Team
Browse more venture capital transactions:
Prev: 7/30/2013: Rover.com venture capital transaction
Next: 7/31/2013: 4INFO venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to record funding rounds that are announced publicly. VC investment data records reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs